Logmore, a Finnish provider of supply chain analytics solutions, announced on Wednesday the launch of a new logistics monitor designed for COVID-19 vaccine delivery.
Logmore Dry Ice, a high-spec version of the company's original data recorder, has been adapted for cold and sub-zero conditions. It is designed for sensitive shipments such as COVID-19 vaccines which require deep freeze storage of as low as -80ºC throughout their journey.
The logger has an additional sensor connected to it with a cable. By placing only the external sensor inside the box, the device can monitor internal temperatures despite remaining outside the box -- allowing it to handle far lower temperatures than comparable products.
The device's ability to monitor temperature, humidity, shocks, tilt and light in real-time will help ensure that life-saving vaccines can be distributed in optimum condition, Logmore said.
AstraZeneca launches online platform to expand patient access to medications
Sanofi increases Sanofi Ventures funding by USD625m to boost biotech and digital health investments
GC Biopharma submits IND application in South Korea for Phase 1 trial of COVID-19 vaccine candidate
AusperBio completes patient enrolment in two Phase II clinical trials of AHB-137
LakeShore Biopharma receives Nasdaq delisting determination letter
Valneva reports strong Phase 2 booster results for Lyme disease vaccine candidate VLA15
GC Biopharma files IND for Phase 3 trial of BARYCELA in Thailand